The enigmatic neutrophil: what we do not know

被引:0
作者
Paul Kubes
机构
[1] University of Calgary,Departments of Physiology and Pharmacology, Microbiology and Immunology and Critical Care Medicine, Snyder Institute for Chronic Disease
来源
Cell and Tissue Research | 2018年 / 371卷
关键词
Neutrophil killing mechanisms; Inflammation; Healing; Imaging; Neutrophil extracellular traps aggregates;
D O I
暂无
中图分类号
学科分类号
摘要
The neutrophil appears to be undergoing a renaissance of sorts. While it was for many years thought to be a killing machine brought into tissues to eradicate pathogens, it is now being implicated in many other processes, ranging from acute injury and repair, chronic inflammatory processes, cancer and auto-immunity. Not only is it an effector of the innate immune response, it appears to also potentially contribute to adaptive immunity, implicated in either contributing to the development of specific adaptive immune responses or perhaps even instructing and directing certain adaptive immune responses. With this renewed interest in the neutrophil and its numerous new functions, it is worth examining not what we know but rather what we do not know and what still needs to be more thoroughly examined. In this review, consideration is given to such topics as neutrophil subtypes, neutrophil differentiation, neutrophil as a director of immunity, neutrophil residency and ultimately death of the neutrophil.
引用
收藏
页码:399 / 406
页数:7
相关论文
共 50 条
[41]   Erosions versus joint space narrowing in rheumatoid arthritis: what do we know? [J].
van der Heijde, Desiree .
ANNALS OF THE RHEUMATIC DISEASES, 2011, 70 :I116-I118
[42]   What do we know about bone morphogenetic proteins and osteochondroprogenitors in inflammatory conditions? [J].
Lukac, Nina ;
Katavic, Vedran ;
Novak, Sanja ;
Sucur, Alan ;
Filipovic, Masa ;
Kalajzic, Ivo ;
Grcevic, Danka ;
Kovacic, Natasa .
BONE, 2020, 137
[43]   What do we know about micronutrients in critically ill patients? A narrative review [J].
de Man, Angelique M. E. ;
Stoppe, C. ;
Koekkoek, W. A. C. ;
Briassoulis, G. ;
Subasinghe, S. D. L. P. ;
Cobilinschi, C. ;
Deane, A. M. ;
Manzanares, W. ;
Grintescu, I. ;
Mirea, L. ;
Roshdy, A. ;
Cotoia, A. ;
Bear, D. E. ;
Boraso, S. ;
Fraipont, V. ;
Christopher, K. B. ;
Casaer, M. ;
Gunst, J. ;
Pantet, O. ;
Elhadi, M. ;
Bolondi, G. ;
Forceville, X. ;
Angstwurm, M. W. A. ;
Gurjar, M. ;
Biondi, R. ;
van Zanten, A. R. H. ;
Berger, M. M. .
JOURNAL OF PARENTERAL AND ENTERAL NUTRITION, 2025, 49 (01) :33-58
[44]   What We Know and What We Need to Know about Aromatic and Cationic Biogenic Amines in the Gastrointestinal Tract [J].
Fernandez-Reina, Alberto ;
Luis Urdiales, Jose ;
Sanchez-Jimenez, Francisca .
FOODS, 2018, 7 (09)
[45]   Chlamydia pneumoniae and atherosclerosis -: what we know and what we don't [J].
Ngeh, J ;
Anand, V ;
Gupta, S .
CLINICAL MICROBIOLOGY AND INFECTION, 2002, 8 (01) :2-13
[46]   What do we know about Toll-Like Receptors Involvement in Gout Arthritis? [J].
Silva, Cassia Regina ;
Saraiva, Andre Lopes ;
Rossato, Mateus Fortes ;
Trevisan, Gabriela ;
Oliveira, Sara Marchesan .
ENDOCRINE METABOLIC & IMMUNE DISORDERS-DRUG TARGETS, 2023, 23 (04) :446-457
[47]   Immune Response Modifications in the Genetic Forms of Parkinson's Disease: What Do We Know? [J].
Magistrelli, Luca ;
Contaldi, Elena ;
Vignaroli, Francesca ;
Gallo, Silvia ;
Colombatto, Federico ;
Cantello, Roberto ;
Comi, Cristoforo .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (07)
[48]   Early knee OA definition-what do we know at this stage? An imaging perspective [J].
Li, Xiaojuan ;
Roemer, Frank W. ;
Cicuttini, Flavia ;
MacKay, Jamie W. ;
Turmezei, Tom ;
Link, Thomas M. .
THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE, 2023, 15
[49]   The role of the autonomic nervous system in acute surgical pain processing - what do we know? [J].
Bantel, C. ;
Trapp, S. .
ANAESTHESIA, 2011, 66 (07) :541-544
[50]   From Bench to Bedside: What Do We Know about Imidazothiazole Derivatives So Far? [J].
Guo, Mu ;
Yu, Xiangbin ;
Zhu, Yi Zhun ;
Yu, Yue .
MOLECULES, 2023, 28 (13)